Major Biotech ETFs Had Lackluster Performance in the Past Month

All three major biotechnology ETFs—the SPDR S&P Biotech ETF (XBI), the iShares NASDAQ Biotechnology Index (IBB), and the ProShares Ultra Nasdaq Biotechnology ETF (BIB)—have posted returns of ~1% in last month, starting on August 10. That compares unfavorably with the performance of the SPDR S&P 500 ETF (SPY), which returned ~1.7% in the same period.

Source: Major Biotech ETFs Had Lackluster Performance in the Past Month

Theranos finally shutting down

Creative Biotech has been covering the blood testing industry and scams infesting it for a couple of years. Tap the image to go to the “In-Focus” page for the complete story.

SQUAWK BOX — Elizabeth Holmes, Theranos CEO and the world’s youngest self-made female billionaire, in an interview on September 29, 2015 — (Photo by: David Orrell/CNBC/NBCU Photo Bank via Getty Images)